Document is current
Any future updates will be listed below
-
Authors
Kotani, Daisuke
Oki, Eiji https://orcid.org/0000-0002-9763-9366
Nakamura, Yoshiaki
Yukami, Hiroki
Mishima, Saori
Bando, Hideaki
Shirasu, Hiromichi
Yamazaki, Kentaro
Watanabe, Jun https://orcid.org/0000-0002-7187-3664
Kotaka, Masahito
Hirata, Keiji
Akazawa, Naoya
Kataoka, Kozo
Sharma, Shruti
Aushev, Vasily N.
Aleshin, Alexey
Misumi, Toshihiro
Taniguchi, Hiroya
Takemasa, Ichiro
Kato, Takeshi
Mori, Masaki
Yoshino, Takayuki https://orcid.org/0000-0002-0489-4756
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (19ck0106447h0002)
- License Information
-
More Information
Article History
Received: 28 July 2022
Accepted: 1 November 2022
First Online: 16 January 2023
Competing interests
: D.K. reports honoraria from Takeda, Chugai, Eli Lilly, MSD, Ono, Taiho, Bristol Myers Squibb, Daiichi-Sankyo, Pfizer, Eisai, Merckbiopharma and Sysmex, and research funding from Ono, MSD, Novartis, Servier, Janssen, IQVIA, Syneoshealth, Cimic and Cimicshiftzero. E.O. reports research funding from Guardant Health, and honoraria from Ono, Takeda, Bayer, Chugai, Taiho, Eli Lilly and Bristol Myers Squibb. Y.N. reports honoraria from Chugai, Merck and Guardant Health AMEA, and research grants from Taiho, Chugai, Guardant Health, Genomedia, Daiichi Sankyo, Seagen and Roche Diagnostics. S.M. reports honoraria from Merck and Roche Diagnostics, and research funding from Roche Diagnostics. H.B. reports research funding from Ono, and honoraria from Ono, Taiho and Eli Lilly. K.Y. reports research funding from Taiho, and honoraria from Takeda, Chugai, Lilly, MSD, Ono, Taiho, Bristol Myers Squibb, Daiichi Sankyo, Merck and Bayer. J.W. reports honoraria for lectures from Johnson & Johnson KK, Medtronic and Eli Lilly, and research funding from Medtronic, AMCO and Terumo outside the submitted work. M.K. reports honoraria from Takeda, Chugai, Lilly, Yakult Honsya and Taiho. K.K. reports honoraria from Takeda, Lilly, Merck and Taiho. H.T. reports honoraria from Chugai, Takeda, Eli Lilly and Merck, and research grants from Taiho, Takeda, Daiichi Sankyo and Roche Diagnostics. I.T. reports honoraria for lectures from Johnson & Johnson KK, Medtronic and Eli Lilly, and research funding from Medtronic and Striker outside the submitted work. T.K. reports honoraria from Chugai, Takeda, Ono, Eli Lilly, Yakult Honsha and Taiho, and research funding from Chugai. T.Y. reports honoraria from Taiho, Chugai, Eli Lilly, Merck, Bayer Yakuhin, Ono and MSD, and research funding from Ono, Sanofi, Daiichi Sankyo, Parexel, Pfizer, Taiho, MSD, Amgen, Genomedia, Sysmex, Chugai and Nippon Boehringer Ingelheim. S.S., V.N.A. and A.A. are full-time employees of Natera with stocks and options to own stock in the company. The remaining authors declare no competing interests.
